human plasma coagulation factor viii

Italy

Drugs containing this active substance

  • HAEMOCTIN

    It is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital factor VIII deficiency).

    Form: solution for injection, powder and solvent

    Active substance Dosage
    human plasma coagulation factor viii -

    ATC: B02BD02

    Manufacturer: BIOTEST PHARMA GMBH

  • KLOTT is used for the treatment and prevention of bleeding in patients with hemophilia A (an inherited deficiency of factor VIII) or in patients presenting with a deficiency of this factor due to other diseases. It is also indicated for hemophilic patients who have developed antibodies against factor VIII (inhibitors).

    Form: solution for infusion, powder and solvent for preparation

    Active substance Dosage
    human plasma coagulation factor viii -

    ATC: B02BD02

    Manufacturer: KEDRION S.P.A.